Live feed07:30:00·21dPRReleasePositive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and TherapySNGX· Soligenix Inc.Health CareOriginal source